ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,180.74
      1.03%
      US Tech 100
      17,604.80
      -0.03%
      Dow Jones
      38,852.27
      0.46%
      Brent Oil
      83.265
      -0.25%
      Bitcoin
      64,230.27
      1.68%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. IR BioSciences Holdings Inc New (CE) (IRBS)

      7. IR BioSciences Holdings Inc New (CE) (IRBS) News

      IRBS

      IR BioSciences (CE) (IRBS)

      IR BioSciences Holdings Inc New (CE)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:IRBS
      DateTimeSourceHeadlineSymbolCompany
      05/24/20115:28PMEdgar (US Regulatory)Annual Report (10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      05/16/20113:11PMEdgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      03/31/201112:54PMEdgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      03/10/20115:29PMEdgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      11/22/20104:12PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      11/12/20108:27AMEdgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      10/28/20109:00AMGlobeNewswire Inc.ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University CollaborationUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      10/01/20104:37PMEdgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      09/08/20107:00AMGlobeNewswire Inc.ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      08/31/20102:21PMGlobeNewswire Inc.ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for InUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      08/25/20109:00AMGlobeNewswire Inc.University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      08/23/20105:15PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      08/13/20104:12PMEdgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      08/05/20108:27AMMarketwired/ CORRECTION - ImmuneRegen BioSciencesUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      08/04/20107:00AMMarketwiredImmuneRegen BioSciences Completes Successful Reduction of DebtUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      07/26/20106:01AMEdgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      05/24/20103:40PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      05/17/201011:51AMEdgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      04/30/20105:17PMEdgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      04/27/20108:00AMMarketwiredImmuneRegen BioSciences(R) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen MeUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      04/21/20108:00AMMarketwiredImmuneRegen BioSciences(R) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead IndicaUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      04/19/20101:00PMMarketwiredImmuneRegen BioSciences(R) Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic PlanningUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      04/15/20104:20PMEdgar (US Regulatory)Annual Report (10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      04/01/20104:01PMEdgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
      03/04/20108:00AMMarketwiredImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary FiUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      02/10/20108:00AMMarketwiredFred Hutchinson Cancer Research Center Initiates Studies on ImmuneRegen BioSciences' Cancer Therapy CandidateUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      01/27/20108:00AMMarketwiredNational Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant CandidateUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      01/26/20102:54PMMarketwiredIR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active CompoundUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      01/05/20108:00AMMarketwiredImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic InfluenzaUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
      12/24/20098:00AMMarketwiredImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development ContinuesUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
       Showing the most relevant articles for your search:USOTC:IRBS